The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Five-year follow-up results of a randomized phase III trial comparing 4 and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer: JCOG1104 (OPAS-1).
 
Souya Nunobe
No Relationships to Disclose
 
Takaki Yoshikawa
Honoraria - AstraZeneca; BMS; Chugai Pharma; Daiichi Sankyo; EA Pharma; Johnson & Johnson/Janssen; Medtronic; Miyarisan pharmaceutical; MSD; Ono Pharmaceutical; Taiho Pharmaceutical; TERUMO
Consulting or Advisory Role - MSD Oncology; TERUMO
Research Funding - Lilly
 
Yasunori Nishida
No Relationships to Disclose
 
Takanobu Yamada
Honoraria - BMS; Johnson & Johnson/Janssen; Ono Pharmaceutical; Taiho Pharmaceutical
 
Masahide Kaji
No Relationships to Disclose
 
Akinori Takagane
No Relationships to Disclose
 
Shin Teshima
No Relationships to Disclose
 
Hisayuki Matsushita
No Relationships to Disclose
 
Ryo Tanaka
No Relationships to Disclose
 
Jun Hihara
No Relationships to Disclose
 
Hiroshi Katayama
No Relationships to Disclose
 
Junki Mizusawa
Employment - Pfizer (I)
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Haruhiko Fukuda
Honoraria - m3.com
 
Narikazu Boku
Honoraria - Bristol-Myers Squibb Japan; Daiichi-Sankyo; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Ono Pharmaceutical (Inst); Takeda (Inst)
 
Masanori Terashima
Honoraria - Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Intuitive Surgical; Johnson & Johnson; Lilly; Medtronic; Olympus; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Ono Pharmaceutical (Inst)